Home > Executive Order

AI Summary: This regulation is an executive order that amends a previous order regarding tariffs on products from the People's Republic of China (PRC) in response to the ongoing synthetic opioid crisis. Specifically, the order increases the ad valorem tariffs from 10 percent to 20 percent on Chinese products, based on the administration's determination that China has not taken adequate steps to address the illicit drug trade. The executive order is issued under the authority of the International Emergency Economic Powers Act (IEEPA) and the National Emergencies Act, and declares the synthetic opioid supply chain as an unusual and extraordinary threat to U.S. national security, foreign policy, and economy. The order includes standard provisions that it does not impair existing executive department authorities and is to be implemented consistent with applicable law.